Seeking Alpha

Shares of Jazz Pharmaceuticals' (JAZZ +15%) jump on a favorable Markman ruling defining the...

Shares of Jazz Pharmaceuticals' (JAZZ +15%) jump on a favorable Markman ruling defining the patent claim terms related to its narcolepsy medication Xyrem. Jefferies analyst Corey Davis says upon first read, the patent construction ruling "seems like a clear win for Jazz."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|